Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 4
Out of 5,182 analysts
136
Total ratings
64.71%
Success rate
147.63%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Underperform | $35 | $51.10 | -31.51% | 1 | Apr 13, 2026 | |
| VCYT Veracyte | Initiates: Buy | $45 | $33.43 | +34.61% | 1 | Apr 13, 2026 | |
| CAI Caris Life Sciences | Initiates: Buy | $28 | $18.44 | +51.84% | 1 | Apr 13, 2026 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 → $1,450 | $1,262.48 | +14.85% | 9 | Mar 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Buy | $215 → $220 | $195.05 | +12.79% | 4 | Feb 11, 2026 | |
| RVTY Revvity | Maintains: Hold | $100 → $105 | $85.18 | +23.27% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $178.98 | +53.65% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $7.86 | +14.50% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $78.23 | +49.56% | 1 | Dec 1, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $300.73 | +28.02% | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $155 | $114.87 | +34.94% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $66.07 | +21.08% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 | $12.02 | +266.06% | 6 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $259.57 | +11.72% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $9.02 | +143.90% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $34.02 | +55.70% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $59.15 | -40.83% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $21.37 | +12.31% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.58 | +153.16% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.59 | +15.83% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $200.17 | -29.06% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $83.09 | -61.49% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $126.92 | -9.39% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $4.84 | +313.22% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $470.22 | +38.23% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.54 | -42.08% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.46 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.93 | +521.76% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $3.34 | +1,696.41% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $5.00 | +360.00% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $166.79 | +133.83% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.01 | +498.01% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $466.64 | -57.14% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $26.49 | -9.40% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $11.78 | +282.00% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $117.43 | -40.39% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $158.98 | -24.52% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.43 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.26 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $9.05 | +508.07% | 1 | Jul 19, 2016 |
Tempus AI
Apr 13, 2026
Initiates: Underperform
Price Target: $35
Current: $51.10
Upside: -31.51%
Veracyte
Apr 13, 2026
Initiates: Buy
Price Target: $45
Current: $33.43
Upside: +34.61%
Caris Life Sciences
Apr 13, 2026
Initiates: Buy
Price Target: $28
Current: $18.44
Upside: +51.84%
Mettler-Toledo International
Mar 20, 2026
Upgrades: Buy
Price Target: $1,400 → $1,450
Current: $1,262.48
Upside: +14.85%
Quest Diagnostics
Feb 11, 2026
Maintains: Buy
Price Target: $215 → $220
Current: $195.05
Upside: +12.79%
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $85.18
Upside: +23.27%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $178.98
Upside: +53.65%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $7.86
Upside: +14.50%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $78.23
Upside: +49.56%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $300.73
Upside: +28.02%
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $114.87
Upside: +34.94%
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $66.07
Upside: +21.08%
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $12.02
Upside: +266.06%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $259.57
Upside: +11.72%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $9.02
Upside: +143.90%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $34.02
Upside: +55.70%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $59.15
Upside: -40.83%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $21.37
Upside: +12.31%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.58
Upside: +153.16%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.59
Upside: +15.83%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $200.17
Upside: -29.06%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $83.09
Upside: -61.49%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $126.92
Upside: -9.39%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $4.84
Upside: +313.22%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $470.22
Upside: +38.23%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.54
Upside: -42.08%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.46
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.93
Upside: +521.76%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $3.34
Upside: +1,696.41%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $5.00
Upside: +360.00%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $166.79
Upside: +133.83%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.01
Upside: +498.01%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $466.64
Upside: -57.14%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $26.49
Upside: -9.40%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $11.78
Upside: +282.00%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $117.43
Upside: -40.39%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $158.98
Upside: -24.52%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.43
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $36.26
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $9.05
Upside: +508.07%